Terms: = Liver cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
68 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma.
Dong R; Wang T; Dong W; Zhu H; Liu Q; Liang H; Chen X; Zhang B; Zhang X
Biomed Pharmacother; 2024 Apr; 173():116366. PubMed ID: 38458013
[TBL] [Abstract] [Full Text] [Related]
3. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/src signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract] [Full Text] [Related]
4. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
5. CDK1-src Interaction-Dependent Transcriptional Activation of HSP90AB1 Promotes Antitumor Immunity in Hepatocellular Carcinoma.
Zhang YJ; Yi DH
J Proteome Res; 2023 Dec; 22(12):3714-3729. PubMed ID: 37949475
[TBL] [Abstract] [Full Text] [Related]
6. prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study.
Yoon JH; Kim SE; Cho SH; Kim GA; Park Y; Park JW; Kang SH; Lee YS; Kim JH
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629725
[No Abstract] [Full Text] [Related]
7. Life span-associated ferroptosis-related genes identification and validation for hepatocellular carcinoma patients as hepatitis B virus carriers.
Weng W; Zhang D; Li S
J Clin Lab Anal; 2023 Jul; 37(13-14):e24930. PubMed ID: 37461802
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Analysis of Prognostic Value and Immune Infiltration of src Family Kinases in Hepatocellular Carcinoma.
Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
[TBL] [Abstract] [Full Text] [Related]
9. ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity.
Dong F; Li H; Liu L; Yao LL; Wang J; Xiang D; Ma J; Zhang G; Zhang S; Li J; Jiang SH; Hu X; Chen J; Bao Z
Int J Biol Sci; 2023; 19(8):2613-2629. PubMed ID: 37215979
[TBL] [Abstract] [Full Text] [Related]
10. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and src.
Chen X; Chen J; Feng W; Huang W; Wang G; Sun M; Luo X; Wang Y; Nie Y; Fan D; Wu K; Xia L
Theranostics; 2023; 13(4):1401-1418. PubMed ID: 36923538
[No Abstract] [Full Text] [Related]
11. Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation.
Li J; Xia Q; Di C; Li C; Si H; Zhou B; Yu S; Li Y; Huang J; Lu Y; Huang M; Liang H; Liu X; Zhao Q
Adv Sci (Weinh); 2023 Mar; 10(7):e2202956. PubMed ID: 36581470
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA-EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the src-YAP signaling axis.
He X; Chen J; Zhou J; Mao A; Xu W; Zhu H; Pan Q; Zhao Y; Zhang N; Wang L; Wang M; Liu Z; Zhu W; Wang L
FASEB J; 2022 Dec; 36(12):e22663. PubMed ID: 36421017
[TBL] [Abstract] [Full Text] [Related]
13. MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
Feng J; Ouyang H; Wang J; Pan D; Sheng L; Xu C; Lin W; Hu D; Chang C; Jia D
Carcinogenesis; 2022 Nov; 43(10):919-929. PubMed ID: 35727197
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a novel Calpain-2-src feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma.
Ma XL; Zhu KY; Chen YD; Tang WG; Xie SH; Zheng H; Tong Y; Wang YC; Ren N; Guo L; Lu RQ
Oncogene; 2022 Jul; 41(27):3554-3569. PubMed ID: 35697802
[TBL] [Abstract] [Full Text] [Related]
15. CD155/src complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Jin AL; Zhang CY; Zheng WJ; Xian JR; Yang WJ; Liu T; Chen W; Li T; Wang BL; Pan BS; Li Q; Cheng JW; Wang PX; Hu B; Zhou J; Fan J; Yang XR; Guo W
Clin Transl Med; 2022 Apr; 12(4):e794. PubMed ID: 35384345
[TBL] [Abstract] [Full Text] [Related]
16. Signaling by the tyrosine kinase Yes promotes liver cancer development.
Guégan JP; Lapouge M; Voisin L; Saba-El-Leil MK; Tanguay PL; Lévesque K; Brégeon J; Mes-Masson AM; Lamarre D; Haibe-Kains B; Trinh VQ; Soucy G; Bilodeau M; Meloche S
Sci Signal; 2022 Jan; 15(717):eabj4743. PubMed ID: 35041461
[TBL] [Abstract] [Full Text] [Related]
17. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
Dong L; Lu D; Chen R; Lin Y; Zhu H; Zhang Z; Cai S; Cui P; Song G; Rao D; Yi X; Wu Y; Song N; Liu F; Zou Y; Zhang S; Zhang X; Wang X; Qiu S; Zhou J; Wang S; Zhang X; Shi Y; Figeys D; Ding L; Wang P; Zhang B; Rodriguez H; Gao Q; Gao D; Zhou H; Fan J
Cancer Cell; 2022 Jan; 40(1):70-87.e15. PubMed ID: 34971568
[TBL] [Abstract] [Full Text] [Related]
18. Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction Network.
Chen D; Zhang Y; Wang W; Chen H; Ling T; Yang R; Wang Y; Duan C; Liu Y; Guo X; Fang L; Liu W; Liu X; Liu J; Otkur W; Qi H; Liu X; Xia T; Liu HX; Piao HL
Adv Sci (Weinh); 2021 Sep; 8(17):e2100311. PubMed ID: 34247449
[TBL] [Abstract] [Full Text] [Related]
19. EPHB2 Activates β-Catenin to Enhance cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
[TBL] [Abstract] [Full Text] [Related]
20. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
Yeeravalli R; Kaushik K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
[TBL] [Abstract] [Full Text] [Related]
[Next]
